Product Information
TROKENDI XR 100 MG CAPSULE is a brand product labeled by Supernus Pharmaceuticals Inc., priced at $30.3781 per EA under NDC 17772010301. Its NADAC has been published 516 times since Dec 31, 2014.
Strength
100 mg/1
Manufacturer
Supernus Pharmaceuticals Inc.NDC
17772010301
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
10/23/2024
Active Ingredients
TOPIRAMATEApproval Type
New Drug (NDA)
FDA Application
NDA201635On Market Since
8/16/2013
Pharmacological Classes
Price Statistics
The NADAC for TROKENDI XR 100 MG CAPSULE has been published 516 times since Dec 31, 2014, and over the history we have for it it has risen 108.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $30.3781 per EA |
|---|---|
| All-time high | $30.5035 (Oct 11, 2023) |
| All-time low | $14.5589 (Dec 31, 2014) |
| Median price | $23.6767 |
| Average price | $24.0245 |
| Largest weekly change | +9.0% (Feb 3, 2016) |
| Weeks tracked | 516 |
| Tracking since | Dec 31, 2014 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 100% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TROKENDI XR 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TROKENDI XR 100 MG CAPSULE, manufactured by Supernus Pharmaceuticals Inc., is $30.3781 per EA (NDC 17772010301), effective Nov 13, 2024.
How has the price of TROKENDI XR 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TROKENDI XR 100 MG CAPSULE has risen 108.7%. It has been tracked across 516 weekly CMS publications since Dec 31, 2014.
What are the highest and lowest recorded NADAC prices for TROKENDI XR 100 MG CAPSULE?
Since Dec 31, 2014, the NADAC for TROKENDI XR 100 MG CAPSULE has ranged from a low of $14.5589 (Dec 31, 2014) to a high of $30.5035 (Oct 11, 2023), with a median of $23.6767 per EA.
Are there cheaper alternatives to TROKENDI XR 100 MG CAPSULE?
Yes. 8 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TOPIRAMATE 100 MG TABLET, is $0.0580 per EA — about 100% below TROKENDI XR 100 MG CAPSULE.
Who manufactures TROKENDI XR 100 MG CAPSULE?
TROKENDI XR 100 MG CAPSULE (NDC 17772010301) is labeled by Supernus Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification